MYD88 Gene

MYD88 Innate Immune Signal Transduction Adaptor (MYD88) is a gene involved in TLR signaling that has been studied in relation to immune function, metabolism, and chronic illness. Variants in MYD88 may influence how the body responds to infection, inflammation, and long-term recovery.

This page is for educational and informational purposes only. Not a diagnostic tool. Always consult a qualified healthcare provider.

What is the MYD88 gene?

MYD88 encodes myd88 innate immune signal transduction adaptor, a protein involved in TLR signaling. It belongs to the Innate Immunity category and is part of the Innate Immunity & Interferons biological cluster. MyD88 is the universal adaptor protein for most Toll-like receptors and IL-1 family receptors. It recruits IRAK kinases to activate NF-κB and MAPK pathways. Inherited MyD88 deficiency causes susceptibility to invasive pneumococcal disease.

Biological role and pathway

MYD88 is involved in the TLR signaling pathway, which plays a central role in regulating physiological processes relevant to immune defence, cellular energy, and systemic homeostasis. Genes within the Innate Immunity & Interferons cluster work together to maintain balanced function across interconnected biological systems.

Variants in genes within this pathway may influence an individual's predisposition to altered function in these systems — particularly under conditions of physiological stress such as viral infection or prolonged illness.

MYD88 and Long COVID / ME-CFS research

MYD88 variants affecting TLR-IL1R signaling may influence COVID-19 susceptibility and the sustained innate immune activation driving Long COVID. Gain-of-function MYD88 mutations are known oncogenic drivers, while loss-of-function increases infection susceptibility.

This information is based on published research and does not constitute medical advice. See references below.

Known genetic variants

The following variants (SNPs) in the MYD88 gene have been studied in relation to innate immunity and chronic illness. Each variant represents a single nucleotide position where individuals may carry different alleles.

Conditions studied in relation to MYD88

Research into MYD88 variants has explored associations with the following conditions. These are areas of scientific investigation and do not imply that MYD88 causes or treats any condition.

Long CovidImmune DysregulationInfection SusceptibilitySystemic Inflammation

Genetic insights from DNA data

Consumer DNA files from 23andMe, AncestryDNA, and MyHeritage contain raw SNP data. When you upload your file to ChronicDNA, the analysis engine checks your genotype against a curated panel of 80+ genes selected for their relevance to Long COVID, ME/CFS, and connected biological pathways - some of which may include MYD88 and related genes in the innate immunity & interferons pathway.

The report is educational - it explains which variants you carry, what the research says about them, and how they fit into the biological pathways most relevant to chronic illness. Results are presented in plain English with appropriate scientific context, no medical jargon, no scare tactics. All results should be discussed with a qualified healthcare provider.

Related genes in the Innate Immunity & Interferons pathway

MYD88 does not act in isolation. The following genes are functionally related and may be analysed together for a more complete picture of your genetic predispositions.

Frequently asked questions

What is the MYD88 gene and what does it do?

MYD88 (MYD88 Innate Immune Signal Transduction Adaptor) is involved in TLR signaling. MyD88 is the universal adaptor protein for most Toll-like receptors and IL-1 family receptors. It recruits IRAK kinases to activate NF-κB and MAPK pathways. Inherited MyD88 deficiency causes susceptibility to invasive pneumococcal disease.

How may MYD88 gene variants relate to Long COVID or ME/CFS?

MYD88 variants affecting TLR-IL1R signaling may influence COVID-19 susceptibility and the sustained innate immune activation driving Long COVID. Gain-of-function MYD88 mutations are known oncogenic drivers, while loss-of-function increases infection susceptibility.

Can a DNA test reveal information about my MYD88 gene?

Consumer DNA data from 23andMe, AncestryDNA, and MyHeritage includes SNP variants for many genes. ChronicDNA analyses your raw DNA file and reports on variants that have been studied in relation to chronic illness, immune function, and metabolism. This is not a diagnostic service — results are informational and educational only.

Explore your MYD88 genetic insights

Upload your DNA data from 23andMe, AncestryDNA, or MyHeritage and receive a personalised report covering >80 genes relevant to Long COVID and ME/CFS.

Get Your Personalised DNA Report

Informational and educational only · Not a diagnostic tool · GDPR compliant

References

The following publications were used in compiling the research context for MYD88. This is not an exhaustive literature review.

  • [1]PMID: 29429640
  • [2]Nature Reviews Immunology
  • [3]Journal of Experimental Medicine